Company-Diagnostics Inc Stock News

NEW YORK, Nov. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CARA, RDHL, BYSI, ATIP, and CODX. To see how InvestorsObserver''s proprietary scoring system rates these stocks, view the InvestorsObserver''s PriceWatch Alert by selecting the corresponding link….

Co-Diagnostics Inc. (NASDAQ: CODX) shares gapped higher Monday, but have since fallen and are now trading lower. The company said today its COVID-19 diagnostics are not affected by the omicron varian

Co-Diagnostics Inc. (NASDAQ: CODX ) shares gapped higher Monday, but have since fallen and are now trading lower. The company said today its COVID-19 diagnostics are not affected by the omicron variant. The variant contains over 50 different mutations, none of which Co-Diagnostics said are expected to interfere with the company''s suite of COVID-19 PCR diagnostic assays. Co-Diagnostics shares were trading down 2.09% at $9.36 late Monday morning. Co-Diagnostics Daily Chart Analysis The stock saw a jump higher, but fell slightly lower in what technical traders call an ascending triangle pattern. The $11 level has been an area of strong resistance in the Full story available on Benzinga.com

NEW YORK , Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, CODX, PRPO, XAIR, and CEMI. … Full story available on Benzinga.com

Co-Diagnostics Inc. (NASDAQ:CODX) shares gapped higher Monday, but have since fallen and are now trading lower. The company said today its COVID-19 diagnostics are not affected by the omicron variant

Co-Diagnostics (NASDAQ:CODX) Inc., which has a patented platform for the development of molecular diagnostic tests, revealed that none of the mutations in the heavily mutated SARS-CoV-2 variant recent

Co-Diagnostics, Inc. (CODX) with the stream of 12.74% also noticed, India Q&K International Group Limited (QK) encountered a rapid change of -7.27% in the last hour of trading session. Co-Diagnostics, The post Stock on fire: Co-Diagnostics, Inc. (NASDAQ:CODX), Q&K International Group Limited (NASDAQ:QK) appeared first on Stocks Equity .

Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024.

Co-Diagnostics (NASDAQ: CODX) has recently received a number of price target changes and ratings updates: 11/15/2021 Co-Diagnostics had its buy rating reaffirmed by analysts at Litchfield Hills Research. 11/15/2021 Co-Diagnostics was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They now have a $10.00 price target []

Co-Diagnostics (NASDAQ:CODX) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share guidance of $1.070-$1.160 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.980. The company issued revenue guidance of $96 million-$100 million, compared to the consensus revenue estimate of $95.21 million. Several brokerages have []

Vanguard Group Inc. increased its position in shares of Co-Diagnostics, Inc. (NASDAQ:CODX) by 1.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,848,637 shares of the companys stock after purchasing an additional 18,163 shares during the period. Vanguard Group Inc. []

The company absolutely crushed analysts' Q3 estimates.

The stock price of Co-Diagnostics Inc (NASDAQ: CODX) increased by over 6% pre-market today. This is why it happened.